Go to search feature Go to content

You need to use a different browser. To be able to use our internet services, you can instead use one of these browsers: Apple Safari, Google Chrome, Microsoft Edge or Mozilla Firefox.

Read more about recommended browsers

SEB Fund 3 - SEB Medical Fund’s merger with SEB Concept Biotechnology is now completed

Risk information

Past performance is not indicative of future results. The value of fund units/shares can rise as well as fall and you may not get back the amount you invested. Funds with a risk level of 5-7 according to the fund’s key information document (KID) can both decrease and increase significantly in value. Fund information, including the KID, prospectus, and sustainability-related disclosures can be found at www.sebgroup.lu/funds.  

The merger took effect on 21 April 2023 and is finalised.

The following funds, both Luxembourg-domiciled, were involved in the merger:

  • SEB Fund 3 - SEB Medical Fund merged with SEB Concept Biotechnology

Now that the merger is effective, the SEB Fund 3 - SEB Medical Fund no longer exists. Customers who had investments in the SEB Fund 3 - SEB Medical Fund are encouraged to read the information about the merger that was published on this website on 7 March 2023.